Discover 5 teas that may support kidney health, from green tea to hibiscus, how tea compares to other drinks, and key ...

When it comes to electrolyte abnormalities, the first things that come to mind are Na and K.Mg (magnesium) might seem like a ...

Three scientific presentations will highlight new analyses of VOQUEZNA® (vonoprazan) in GERD, including real-world patient characteristics, efficacy across BMI subgroups, and cost-effectiveness in ...

Trastuzumab Deruxtecan Approved in China for HER2-Positive Early Breast Cancer With Residual Disease / 2025 European Society ...

Hair repair is a lot like fixing a house,” says Tina Mui, trichologist, hairstylist, and founder of AWARE Hair. “Sometimes ...

In 2015, a new class of cholesterol-lowering injectable drugs called PCSK9-inhibitors was approved by the Food and Drug ...

What to do when shocks are repeatedWe have looked at ATP (see separate article "ATP (Anti-Tachycardia Pacing)") and ...

Patients with lower limb lymphedema, which has few effective treatments, saw many of their symptoms improve after a year of ...

Initiation of registrational Phase 3 study of VOQUEZNA® (vonoprazan) for as-needed (PRN) use in Non-Erosive Reflux Disease (NERD) builds on ...

Fibrodysplasia ossificans progressiva (FOP) is among the most devastating musculoskeletal disorders. FOP is caused by activating variants in ACVR1, most often arising de novo, and is characterised by ...

EXXUA net revenue was $6.6 million during fiscal 2026. EXXUA was made commercially available in mid-December 2025, and more formally launched in mid-January 2026 following the completion of sales ...